What the WHO Snub Means For Ocugen Stock Investors?

InvestorPlace2022-04-05

The World Health Organization (WHO)has suspended Covid-19 vaccine Covaxin through United Nations supply agencies. The setback is yet another entry in the seemingly never-ending woes for U.S. biotech ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

NP_YT
2022-04-05
NP_YT
Good
NP_YT
2022-04-05
NP_YT
Good
koolgal
2022-04-05
koolgal
Ocugen is facing strong headwinds when WHO suspended the distribution of its vaccines due to QC issues. That's why its share price dropped. 🤔
claratan
2022-04-05
claratan
Wow
TeslaLegend
2022-04-05
TeslaLegend
Nice
yyhwin
2022-04-05
yyhwin
Hi

Leave a comment

288

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1190860254?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-04-05 13:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1190860254","market":"us","top_or_hot":-1,"title":"What the WHO Snub Means For Ocugen Stock Investors?","media":"InvestorPlace","content":"<div>\n<p>The World Health Organization (WHO)has suspended Covid-19 vaccine Covaxin through United Nations supply agencies. The setback is yet another entry in the seemingly never-ending woes for U.S. biotech ...</p>\n\n<a href=\"https://investorplace.com/2022/04/what-the-who-snub-means-for-ocgn-stock-investors/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What the WHO Snub Means For Ocugen Stock Investors?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat the WHO Snub Means For Ocugen Stock Investors?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-05 13:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/04/what-the-who-snub-means-for-ocgn-stock-investors/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The World Health Organization (WHO)has suspended Covid-19 vaccine Covaxin through United Nations supply agencies. The setback is yet another entry in the seemingly never-ending woes for U.S. biotech ...</p>\n\n<a href=\"https://investorplace.com/2022/04/what-the-who-snub-means-for-ocgn-stock-investors/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OCGN","symbol_name":"Ocugen","start_time":0,"source_url":"https://investorplace.com/2022/04/what-the-who-snub-means-for-ocgn-stock-investors/","article_id":"1190860254","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190860254","pubTimestamp":1649137986,"sourceInfo":{"source_id":"lsy1606302653667","name":"InvestorPlace"},"weMediaInfo":null,"summary":"The World Health Organization (WHO)has suspended Covid-19 vaccine Covaxin through United Nations sup","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"OCGN":"Ocugen"},"translate_title":"世界卫生组织的冷落对Ocugen股票投资者意味着什么？","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OCGN":0.9},"content_text":"The World Health Organization (WHO)has suspended Covid-19 vaccine Covaxin through United Nations supply agencies. The setback is yet another entry in the seemingly never-ending woes for U.S. biotech Ocugen(NASDAQ:OCGN), which hopes to commercialize Covaxin in North America and kick-start a bull run in OCGN stock.Following an emergency use listing (EUL) inspection that took place in mid-March, the WHO announced over the weekend that it recommends countries that received Covaxin vaccines take appropriate measures. Though the organization did not offer specifics, it cited good manufacturing practices (GMP) deficiencies in the vaccine’s production.The suspension is meant to give Ocugen’s partner, India’s Bharat Biotech, time to complete facility and process upgrades to rectify the issues found in the inspection. Although the WHO said there were no safety or efficacy issues, the suspension is likely to disrupt the supply of Covaxin.OCGN stock opened lower Monday but rebounded to close the day up 4.6%. Shares are up 47% in the past three weeks but down 27% year to date and more than 80% from their November high.Earlier in 2021, OCGN stock soared more than 700% on news of the Covaxin co-commercialization deal. However, its efforts to commercialize the vaccine in North America haven’t borne fruit thus far, and many are saying it’s too little too late for the company.Covaxin’s nod of approval from the WHO has perhaps the biggest positive development for Ocugen after the vaccine got snubbed by the U.S. Food and Drug Administration (FDA). With the WHO’s recent suspension, there seems to be little here for long-term investors.Expect a bumpy road ahead for OCGN stock as it looks to mount a recovery. Perhaps investors could revisit the company based on its work in eye diseases in the long term.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9016805004,"gmtCreate":1649162271953,"gmtModify":1676534460928,"author":{"id":"3572043809285615","authorId":"3572043809285615","name":"NP_YT","avatar":"https://static.itradeup.com/news/fad9f70abb174e3e09e4caf3f9c0c13a","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3572043809285615","idStr":"3572043809285615"},"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9016805004","repostId":1190860254,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9016802518,"gmtCreate":1649162229662,"gmtModify":1676534460945,"author":{"id":"3572043809285615","authorId":"3572043809285615","name":"NP_YT","avatar":"https://static.itradeup.com/news/fad9f70abb174e3e09e4caf3f9c0c13a","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3572043809285615","idStr":"3572043809285615"},"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9016802518","repostId":1190860254,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9016175632,"gmtCreate":1649160726740,"gmtModify":1676534460745,"author":{"id":"3559581955535845","authorId":"3559581955535845","name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":6,"crmLevelSwitch":1,"authorIdStr":"3559581955535845","idStr":"3559581955535845"},"htmlText":"Ocugen is facing strong headwinds when WHO suspended the distribution of its vaccines due to QC issues.&nbsp; That's why its share price dropped. 🤔","listText":"Ocugen is facing strong headwinds when WHO suspended the distribution of its vaccines due to QC issues.&nbsp; That's why its share price dropped. 🤔","text":"Ocugen is facing strong headwinds when WHO suspended the distribution of its vaccines due to QC issues. That's why its share price dropped. 🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9016175632","repostId":1190860254,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9016146553,"gmtCreate":1649158431896,"gmtModify":1676534460428,"author":{"id":"3573731928321338","authorId":"3573731928321338","name":"claratan","avatar":"https://static.tigerbbs.com/9c6bbdac9048ff2e4b740f272576e2be","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3573731928321338","idStr":"3573731928321338"},"htmlText":"Wow&nbsp;","listText":"Wow&nbsp;","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9016146553","repostId":1190860254,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9016157981,"gmtCreate":1649156701985,"gmtModify":1676534460221,"author":{"id":"3572489627147183","authorId":"3572489627147183","name":"TeslaLegend","avatar":"https://static.tigerbbs.com/180ad6f06095bcbf2b6594d26c494752","vip":1,"hat":"https://static.tigerbbs.com/f84859c65fc2d7681e28f6b8e9b0535a","crmLevel":4,"crmLevelSwitch":1,"authorIdStr":"3572489627147183","idStr":"3572489627147183"},"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9016157981","repostId":1190860254,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9016187515,"gmtCreate":1649149533074,"gmtModify":1676534459375,"author":{"id":"3581931076615563","authorId":"3581931076615563","name":"yyhwin","avatar":"https://static.tigerbbs.com/78727032603c2751ac0b6b6cfb678920","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":2,"crmLevelSwitch":1,"authorIdStr":"3581931076615563","idStr":"3581931076615563"},"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9016187515","repostId":1190860254,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":288,"commentSize":8,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1190860254"}